Sign Up to like & get
recommendations!
0
Published in 2017 at "Cell Death and Differentiation"
DOI: 10.1038/cdd.2016.124
Abstract: All current regimens for treating ovarian cancer center around carboplatin as standard first line. The HSP90 inhibitor ganetespib is currently being assessed in advanced clinical oncology trials. Thus, we tested the combined effects of ganetespib…
read more here.
Keywords:
hsp90 inhibition;
fragmentation;
ovarian cancer;
dna ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Cardiovascular research"
DOI: 10.1093/cvr/cvz194
Abstract: AIMS Adventitial remodeling presenting with the phenotypic switch of adventitial fibroblasts (AFs) to myofibroblasts (MFs) is reportedly involved in the evolution of several vascular diseases, including hypertension. In our previous study, we reported that heat…
read more here.
Keywords:
fission;
mitochondrial fission;
adventitial remodeling;
hsp90 inhibition ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "PLoS ONE"
DOI: 10.1371/journal.pone.0202758
Abstract: Response of tumours to Hsp90 inhibitors is highly variable and their clinical effects are unpredictable, emphasising the need for a predictive marker. We postulated that sensitivity to Hsp90 inhibitors is connected to basal proteotoxic stress…
read more here.
Keywords:
sensitivity;
hsp90 inhibition;
proteotoxic stress;
hsf1 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.22142
Abstract: Hyperthermia – application of supra-physiological temperatures to cells, tissues or organs – is a pleiotropic treatment that affects most aspects of cellular metabolism, but its effects on DNA are of special interest in the context…
read more here.
Keywords:
hyperthermia;
treatment;
hyperthermia based;
hsp90 inhibition ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1005045
Abstract: Response resistance to the immune checkpoint blockade (ICB) immunotherapy remains a major clinical challenge that may be overcome through the rational combination of ICB and specific targeted therapeutics. One emerging combination strategy is based on…
read more here.
Keywords:
immune checkpoint;
response;
checkpoint blockade;
hsp90 inhibition ... See more keywords